Evidence map›Paper›PMID 21707993›Full record

Trial reportBMC cardiovascular disorders2011

Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis.

Hanna Pohjantähti-Maaroos, Ari Palomäki, Juha Hartikainen

Registry-linked trialOpen access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in BMC cardiovascular disorders, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01119404 (Hämeenlinna Metabolic Syndrome Research Program), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01119404 unknown statusnot on this map

Hämeenlinna Metabolic Syndrome Research Program (HMS): Surrogate Indicators for Atherosclerosis in Men With Metabolic Syndrome, Coronary Heart Disease and Controls

TypeobservationalSponsorKanta-Häme Central HospitalRan2003 to 2014Enrolled300ConditionsMetabolic Syndrome, Coronary Heart Disease
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Metabolic syndrome and risk for ED: a meta-analysis.International journal of impotence research
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Usefulness of serum fetuin-A level as a marker of erectile dysfunction.International journal of impotence research · 2017
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Carotid artery intima-media thickness and erectile dysfunction in patients with metabolic syndrome.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  14. Review
  15. Low serum melatonin levels are associated with erectile dysfunction.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hanna Pohjantähti-MaaroosDepartment of Emergency Medicine, Kanta-Häme Central Hospital, Hämeenlinna, Finland. hanna.pohjantahti-maaroos@kuh.fi
Ari Palomäki
Juha Hartikainen
Kanta-Hämeen Keskussairaala · FIKuopio University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundErectile dysfunction (ED), impaired arterial elasticity, elevated resting heart rate as well as increased levels of oxidized LDL and fibrinogen associate with future cardiovascular events. Physical activity is crucial in the prevention of cardiovascular diseases (CVD), while metabolic syndrome (MetS) comprises an increased risk for CVD events. The aim of this study was to assess whether markers of subclinical atherosclerosis are associated with the presence of ED and MetS, and whether physical activity is protective of ED.

methods57 MetS (51.3 ± 8.0 years) and 48 physically active (PhA) (51.1 ± 8.1 years) subjects participated in the study. ED was assessed by the International Index of Erectile Function (IIEF) questionnaire, arterial elasticity by a radial artery tonometer (HDI/PulseWave™ CR-2000) and circulating oxLDL by a capture ELISA immunoassay. Fibrinogen and lipids were assessed by validated methods. The calculation of mean daily energy expenditure of physical exercise was based on a structured questionnaire.

resultsED was more often present among MetS compared to PhA subjects, 63.2% and 27.1%, respectively (p < 0.001). Regular physical exercise at the level of > 400 kcal/day was protective of ED (OR 0.12, 95% CI 0.017-0.778, p = 0.027), whereas increased fibrinogen (OR 4.67, 95% CI 1.171-18.627, p = 0.029) and elevated resting heart rate (OR 1.07, 95% CI 1.003-1.138, p = 0.04) were independently associated with the presence of ED. In addition, large arterial elasticity (ml/mmHgx10) was lower among MetS compared to PhA subjects (16.6 ± 4.0 vs. 19.6 ± 4.2, p < 0.001), as well as among ED compared to non-ED subjects (16.7 ± 4.6 vs. 19.0 ± 3.9, p = 0.008). Fibrinogen and resting heart rate were highest and large arterial elasticity lowest among subjects with both MetS and ED.

conclusionsMarkers of subclinical atherosclerosis associated with the presence of ED and were most evident among subjects with both MetS and ED. Thus, especially MetS patients presenting with ED should be considered at high risk for CVD events. Physical activity, on its part, seems to be protective of ED.

trial registrationClinicalTrials.gov NCT01119404.

Indexed as

AdultAtherosclerosisBiomarkersCross-Sectional StudiesErectile DysfunctionHeart RateHumansLipoproteins, LDLMaleMetabolic SyndromeMiddle AgedMotor ActivityRisk FactorsSurveys and QuestionnairesVasodilationBiomarkersLipoproteins, LDLoxidized low density lipoprotein

Identifiers

PMID21707993
PMCPMC3157429
OpenAlexW2073826016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.